PAREXEL Launches Next Generation Analytics Capabilities within Perceptive MyTrials® Platform

PAREXEL Launches Next Generation Analytics Capabilities within Perceptive MyTrials® Platform PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its Perceptive MyTrials® platform with advanced analytics capabilities.  With the Perceptive MyTrials Analytics solution, clinical trial sponsors can now use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously.  The ... Read More »

Bristol-Myers’ Evotaz gets European approval to treat HIV-1 infection

Bristol-Myers’ Evotaz gets European approval to treat HIV-1 infection Bristol-Myers Squibb has received approval from the European Commission for Evotaz, a fixed-dose combination of atazanavir and cobicistat, to treat HIV-1 Infection in adults. Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with ... Read More »

Finding Happiness

Finding Happiness Once a group of 50 people was attending a seminar. Suddenly the speaker stopped and started giving each person a balloon. Each one was asked to write his/her name on it using a marker pen. Then all the balloons were collected and put in another room. Now these delegates were let in that room and asked to find ... Read More »

Chemotherapeutic coatings enhance tumour-frying nanoparticles: Study

Chemotherapeutic coatings enhance tumour-frying nanoparticles: Study The photothermal therapy is already being tested for several types of cancers in clinical trials conducted by Nanospectra Biosciences Researchers at Duke University have devised a method for making a promising nanoscale cancer treatment even more deadly to tumours. The invention allows an extremely thin layer of hydrogels (think contact lenses) to be deposited on ... Read More »

Union Minister of Chemicals and Fertilisers launches pharma price data bank

Union Minister of Chemicals and Fertilisers launches pharma price data bank Pharma price data bank is an integrated pharmaceutical database management system, managed and operated by National Pharmaceutical Pricing Authority The Union Minister of Chemicals and Fertilisers, Ananth Kumar launched pharma price data bank. It is an integrated pharmaceutical database management system, managed and operated by National Pharmaceutical Pricing Authority (NPPA). ... Read More »

The Lost Camel

The Lost Camel Once two merchants lost a camel. They met a traveller and asked him if he had seen it. The man replied he had not.” But was your camel blind in the right eye?” Said he to them. “Yes, he was”, replied the merchants. “Was it lame in one left foot?” The man asked again. “Cer­tainly it was”, ... Read More »

AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen

AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen CAMBRIDGE, Mass. — Biogen, Inc. and AGTC (AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, entered into an agreement worth more than $1 billion to develop gene-based therapies for multiple ophthalmic diseases, the two companies announced this morning. ... Read More »

Stay grounded :: When you fly high

Stay grounded :: When you fly high Father is flying a kite. His son is watching him carefully. After some time son says “Dad. Because of the string the kite is not able to go any further higher.” Hearing this, the father smiles and breaks the string.     The kite goes higher after breaking of the thread and then ... Read More »

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m Swiss drugmaker Novartis has strengthened its presence in pain management by agreeing to acquire a US-Australia biotech firm Spinifex Pharmaceuticals for more than $200m. Spinifex is focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a new angiotensin II Type 2 receptor (AT2R) antagonist. EMA401 is ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com